A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function.
<h4>Introduction</h4>Delayed graft function (DGF) following renal transplantation is a manifestation of acute kidney injury (AKI) leading to poor long-term outcome. Current treatments have limited effectiveness in preventing DGF. Interleukin-18 (IL18), a biomarker of AKI, induces interfe...
Main Authors: | E Wlodek, R B Kirkpatrick, S Andrews, R Noble, R Schroyer, J Scott, C J E Watson, M Clatworthy, E M Harrison, S J Wigmore, K Stevenson, D Kingsmore, N S Sheerin, O Bestard, H A Stirnadel-Farrant, L Abberley, M Busz, S DeWall, M Birchler, D Krull, K S Thorneloe, A Weber, L Devey |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0247972 |
Similar Items
-
GSK-3𝜷: A Bifunctional Role in Cell Death Pathways
by: Keith M. Jacobs, et al.
Published: (2012-01-01) -
Podocyte GSK3 is an evolutionarily conserved critical regulator of kidney function
by: J. A. Hurcombe, et al.
Published: (2019-01-01) -
GSK-3 mouse models to study neuronal apoptosis
by: Raquel eGomez-Sintes, et al.
Published: (2011-11-01) -
Novel reporter alleles of GSK-3α and GSK-3β.
by: William B Barrell, et al.
Published: (2012-01-01) -
GSK-3 and mitochondria in cancer cells
by: Andrea eRasola, et al.
Published: (2013-02-01)